Clincosm LogoSign in Get a demo

Glioblastoma Multiforme

Showing NaN - NaN of 38
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)

Not yet recruiting
  • High Grade Glioma
  • +8 more
  • Aurora, Colorado
  • +17 more
May 2, 2023

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023

    Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity

    Recruiting
    • Astrocytoma, Grade IV
    • +3 more
    • CYNK-001 systemic and Intra cavity administration
    • Duarte, California
    • +5 more
    Jan 20, 2023

    Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

    Recruiting
    • Glioblastoma Multiforme
    • +5 more
    • Los Angeles, California
    • +12 more
    Jan 9, 2023

    Glioblastoma Multiforme Trial in United States (TPI 287, Bevacizumab)

    Suspended
    • Glioblastoma Multiforme
    • Birmingham, Alabama
    • +8 more
    Jul 19, 2022

    Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)

    Active, not recruiting
    • Glioblastoma Multiforme
    • +6 more
    • Dendritic cell immunotherapy
    • Birmingham, Alabama
    • +85 more
    May 12, 2022

    Glioblastoma Multiforme Trial in Canada, United States (drug, radiation, device)

    Recruiting
    • Glioblastoma Multiforme
    • Birmingham, Alabama
    • +17 more
    Apr 1, 2022

    Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)

    Active, not recruiting
    • Glioma
    • +4 more
    • VAL-083, Dianhydrogalactitol
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Mar 23, 2022

    Brain and CNS Tumors, Glioblastoma Multiforme Trial in United States (Celecoxib, Isotretinoin, Temozolomide)

    Completed
    Has Results
    • Brain and Central Nervous System Tumors
    • Glioblastoma Multiforme
    • Fort Smith, Arkansas
    • +11 more
    Sep 21, 2021

    Glioblastoma Multiforme, Squamous Cell Carcinoma of Head and Neck, Prostate Cancer Trial in Worldwide (CC-115)

    Completed
    • Glioblastoma Multiforme
    • +5 more
    • Los Angeles, California
    • +16 more
    Oct 4, 2021

    Glioblastoma Multiforme, Anaplastic Oligoastrocytoma Trial in United States (Ad-RTS-hIL-12, veledimex)

    Completed
    • Glioblastoma Multiforme
    • Anaplastic Oligoastrocytoma
    • Los Angeles, California
    • +5 more
    Sep 21, 2021

    Glial Cell Tumors, Malignant Gliomas, Glioblastoma Multiforme Trial in United States (Valproic acid, Bevacizumab, Radiation

    Completed
    Has Results
    • Glial Cell Tumors
    • +7 more
    • Valproic acid
    • +2 more
    • Oklahoma City, Oklahoma
    • +5 more
    Jun 30, 2021

    Glioblastoma Multiforme Trial in Worldwide (drug, other, radiation)

    Terminated
    Has Results
    • Glioblastoma Multiforme
    • Steroid eye drops
    • +6 more
    • Los Angeles, California
    • +21 more
    Mar 19, 2021

    Glioblastoma Multiforme, Anaplastic Glioma Trial in Houston (Vorinostat, Isotretinoin, Surgical Resection)

    Active, not recruiting
    • Glioblastoma Multiforme
    • Anaplastic Glioma
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Oct 29, 2020

    Glioblastoma Multiforme Trial in Houston (Temozolomide, R115777)

    Completed
    Has Results
    • Glioblastoma Multiforme
    • Houston, Texas
      MD Anderson Cancer Center
    Sep 1, 2020

    Glioblastoma Multiforme, Astrocytoma, Grade III Trial in Houston (ADV/HSV-tk (gene therapy))

    Recruiting
    • Glioblastoma Multiforme
    • Astrocytoma, Grade III
    • ADV/HSV-tk (gene therapy)
    • Houston, Texas
      Houston Methodist Neurological Institute
    Sep 3, 2020

    Hematological Tumors, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in United States (CC-486, Vidaza)

    Completed
    • Hematological Neoplasms
    • +19 more
    • Scottsdale, Arizona
    • +9 more
    May 11, 2020

    Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Worldwide (Toca 511, Toca FC, Lomustine)

    Terminated
    • Glioblastoma Multiforme
    • Anaplastic Astrocytoma
    • Toca 511
    • +4 more
    • Phoenix, Arizona
    • +66 more
    Feb 6, 2020

    Glioblastoma Multiforme Trial in United States (Cilengitide 500 mg, Cilengitide 2000 mg)

    Completed
    Has Results
    • Glioblastoma Multiforme
    • Cilengitide 500 mg
    • Cilengitide 2000 mg
    • Birmingham, Alabama
    • +16 more
    Jan 18, 2019

    Glioblastoma Multiforme Trial in Houston (Temozolomide and SCH66336)

    Completed
    • Glioblastoma Multiforme
    • Temozolomide and SCH66336
    • Houston, Texas
      UTMD Anderson Cancer Center
    Oct 25, 2018

    Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (FDOPA PET)

    Terminated
    • Glioma
    • +2 more
    • FDOPA PET
    • Houston, Texas
      Houston Methodist Research Institute PET Center
    Aug 15, 2018

    Glioblastoma Multiforme Trial in Austria, Canada, United States (ICT-107, Placebo)

    Suspended
    • Glioblastoma Multiforme
    • ICT-107
    • Placebo
    • Birmingham, Alabama
    • +64 more
    Aug 9, 2018

    Glioblastoma Multiforme Trial in United States (TPI 287, Bevacizumab)

    Terminated
    • Glioblastoma Multiforme
    • Birmingham, Alabama
    • +10 more
    Jan 30, 2018

    Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in United States (AdV-tk, Valacyclovir)

    Completed
    • Malignant Glioma
    • +2 more
    • Duarte, California
    • +3 more
    Apr 8, 2017

    Glioblastoma Multiforme Trial in Worldwide (NovoTTF-100A device, Temozolomide)

    Completed
    • Glioblastoma Multiforme
    • Birmingham, Alabama
    • +88 more
    Apr 7, 2017